Literature DB >> 10463847

Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis.

A Kaminska1, A Ickowicz, P Plouin, M F Bru, G Dellatolas, O Dulac.   

Abstract

PURPOSE: To distinguish various types of childhood severe cryptogenic/idiopathic generalised epilepsy on the basis of reproducible diagnostic criteria, using multiple correspondence analysis (MCA).
METHODS: We applied MCA to a series of 72 children with no evidence of brain damage, starting epilepsy between 1 and 10 years, with two or more types of generalised seizures. We excluded patients with infantile spasms or typical absences. MCA was performed on all clinical and EEG parameters, first throughout follow-up, then restricted to the first year of the disease.
RESULTS: When including all follow-up variables, there were three groups: (1) Thirty-seven children with male predominance, familial history of epilepsy, simple febrile convulsions, massive myoclonus, tonic-clonic fits. Outcome was favourable, with no seizures and mildly affected cognitive functions. Interictal EEG showed short sequences of irregular 3-Hz spike-waves. (2) In 18 children, clinical characteristics were similar to those of the first group at the early stage, but 95% exhibited myoclonic status and vibratory tonic seizures, with persisting seizures on follow-up. EEG showed long sequences of generalised irregular spike and slow waves. Those two groups meet the characteristics of childhood onset myoclonic-astatic epilepsy (MAE) with respectively, favourable and unfavourable outcome. (3) Eleven children had later onset, atypical absences, tonic and partial seizures, and no myoclonus, or vibratory tonic seizures. All had mental retardation and persisting seizures. EEG showed long sequences of slow spike-wave activity and half the patients had spike and slow wave foci. These patients met the major characteristics of Lennox-Gastaut syndrome. Initial parameters failed to distinguish the first two groups, but Lennox-Gastaut syndrome (the third group) was distinct from both groups of myoclonic astatic epilepsy from the onset. Within MAE groups combined, clinical and EEG risk factors for mental retardation could be identified.
CONCLUSION: It is possible to validate statistically the distinction between discrete epileptic syndromes. Myoclonic astatic epilepsy is therefore distinct from Lennox-Gastaut syndrome, and the distinction appears from the first year of the disorder.

Entities:  

Mesh:

Year:  1999        PMID: 10463847     DOI: 10.1016/s0920-1211(99)00021-2

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  13 in total

Review 1.  Neuropsychological deficits in childhood epilepsy syndromes.

Authors:  William S MacAllister; Sarah G Schaffer
Journal:  Neuropsychol Rev       Date:  2007-10-26       Impact factor: 7.444

2.  EEG for children with complex febrile seizures.

Authors:  Pankaj B Shah; Saji James; Sivaprakasam Elayaraja
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

3.  Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures.

Authors:  Gemma L Carvill; Jacinta M McMahon; Amy Schneider; Matthew Zemel; Candace T Myers; Julia Saykally; John Nguyen; Angela Robbiano; Federico Zara; Nicola Specchio; Oriano Mecarelli; Robert L Smith; Richard J Leventer; Rikke S Møller; Marina Nikanorova; Petia Dimova; Albena Jordanova; Steven Petrou; Ingo Helbig; Pasquale Striano; Sarah Weckhuysen; Samuel F Berkovic; Ingrid E Scheffer; Heather C Mefford
Journal:  Am J Hum Genet       Date:  2015-04-09       Impact factor: 11.025

4.  Understanding Lennox-Gastaut syndrome: insights from focal epilepsy patients with Lennox-Gastaut features.

Authors:  Sophie Dupont; Raluca Banica-Wolters; Isabelle An-Gourfinkel; Virginie Lambrecq; Vincent Navarro; Claude Adam; Vi-Huong Nguyen-Michel
Journal:  J Neurol       Date:  2017-06-05       Impact factor: 4.849

Review 5.  Valproate as a mainstay of therapy for pediatric epilepsy.

Authors:  Renzo Guerrini
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 6.  Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts.

Authors:  Markus von Deimling; Ingo Helbig; Eric D Marsh
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

7.  Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures.

Authors:  Krista Eschbach; Angela Moss; Charuta Joshi; Katie Angione; Garnett Smith; Amanda Dempsey; Elizabeth Juarez-Colunga; Scott T Demarest
Journal:  Epilepsy Res       Date:  2018-09-24       Impact factor: 3.045

8.  Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up.

Authors:  Isabelle Desguerre; Christo Christov; Michele Mayer; Reinhard Zeller; Henri-Marc Becane; Sylvie Bastuji-Garin; France Leturcq; Catherine Chiron; Jamel Chelly; Romain K Gherardi
Journal:  PLoS One       Date:  2009-02-05       Impact factor: 3.240

9.  Evolution and course of early life developmental encephalopathic epilepsies: Focus on Lennox-Gastaut syndrome.

Authors:  Anne T Berg; Susan R Levy; Francine M Testa
Journal:  Epilepsia       Date:  2018-09-26       Impact factor: 5.864

Review 10.  EEG for children with complex febrile seizures.

Authors:  Pankaj B Shah; Saji James; S Elayaraja
Journal:  Cochrane Database Syst Rev       Date:  2017-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.